Skip to main content
Adult provider role in transition of care for young adult pediatric recipients of liver transplant: An expert position statement.
Pragmatic strategies to address health disparities along the continuum of care in chronic liver disease.
Protein biomarkers GDF15 and FGF21 to differentiate mitochondrial hepatopathies from other pediatric liver diseases.
Nutrition assessment and MASH severity in children using the Healthy Eating Index.
Neonatal cholestasis in children with Alpha-1-AT deficiency is a risk for earlier severe liver disease with male predominance.
Diagnosis and management of Alagille and progressive familial intrahepatic cholestasis.
Sarcopenia is associated with osteopenia and impaired quality of life in children with genetic intrahepatic cholestatic liver disease.
Safety and yield of percutaneous liver biopsy in adults and children with chronic hepatitis B: Results from a prospective, multicenter study.
Clinical spectrum and genetic causes of mitochondrial hepatopathy phenotype in children.
Elbasvir/grazoprevir in children aged 3-18 years with chronic HCV genotype 1 or 4 infection: a pharmacokinetic modeling study.